DEC 4, 2025
Building a biotech: Enabling a successful digital drug discovery program with a connected platform
Translating your scientific hypotheses into promising lead compounds is complex and time-sensitive. In order to design better compounds and make faster decisions, your team needs to be able to confidently move ideas through the design-make-test-analyze (DMTA) cycle – from building accurate 3D models to iterating together on new designs to analyzing in silico and experimental data in real time.
It’s time to transform your drug discovery process. In this exclusive webinar, we will go beyond theory to provide a live demonstration of how Schrödinger’s flagship platforms, Maestro and LiveDesign, work together to create a unified, collaborative discovery workflow made available to the entire project team, from modelers to medicinal chemists.
We will show you how to leverage the power of Maestro to construct robust predictive models with precise 3D structural data. Then, we’ll demonstrate the seamless deployment of these models directly into the LiveDesign environment. You’ll see firsthand how computational and medicinal chemists can use these models to quickly test new ideas, evaluate designs, and collaborate with their team in a single, integrated platform.
Join us to see how this powerful solution can accelerate your DMTA cycles and enable your teams – this isn’t about complex simulations, it’s about giving your team the tools they need to make better decisions, faster.
Webinar Highlights:
- Maximize the value of your data: We’ll show you how to create predictive models using Maestro and integrate these in silico results with your experimental data in LiveDesign for real-time, centralized analysis
- Empower collaboration across teams and CROs: We’ll demonstrate how the LiveDesign platform facilitates sharing and tracking of data for improved collaboration
- Get started: We’ll show you how Schrödinger’s world-class support team makes implementation and training easy to enable your success
- Ask questions: Schrödinger experts will be on hand to answer any questions you may have
Our Speakers
Kevin Halligan
Vice President, Schrödinger
Kevin Halligan joined Schrödinger in 2014, and currently serves as a Vice President, Sales, where he is responsible for the growth and management of the company’s life science software and drug discovery services business in the US and Canada. He completed his MS in Biological and Pharmaceutical Biotechnology at St. John’s University and holds a BA in Communication and Media Studies from Fordham University. He has extensive experience in scientific sales and business development and a proven track record of growing the Schrödinger Platform. Kevin’s tenure at Schrödinger has afforded him a comprehensive understanding of the preclinical drug discovery process and the opportunity to directly impact the computational drug discovery revolution.
Paul Sanschagrin
Lead Strategic Deployment Manager, Schrödinger
Paul Sanschagrin joined Schrödinger in 2018 and serves as a Lead Strategic Deployment Manager supporting LiveDesign and the Schrodinger platform across diverse customers, including major global pharma customers and several biotech customers. Paul received his BS in Biochemistry and PhD in Biochemistry from Michigan State University with a postdoctoral position at Philipps-Universität Marburg, Germany. Paul’s background in computational chemistry and drug discovery alongside his past experience in technical roles including software support and systems administration enable him to bridge the gap between the scientists’ needs and the technical possibilities to effectively deliver the Schrödinger Platform.